Ureteric and renal stones
Conditions
Interventions
A group that ureteral stent tail is left inside the bladder without crossing the midline.
A group that ureteral stent tail is left inside the bladder crossing the midline.
Sponsors
Osaka Saiseikai Izuo Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1, Over 20 years old 2. Patients who can describe the questionnaire 3. Patients who can understand this study 4, patients undergoing TUL for upper urinary calculi
Exclusion criteria
Exclusion criteria: 1) Active urinary tract infection 2) Concomitant medication with alpha blockers, antimuscarinics, analgesics, beta-3 agonist, PDE 5 inhibitor 3) Pregnancy 8) Ureteral stent placement before TUL 9) Bilateral ureteral stenting 10) Bladder cancer 11) Prostate cancer 12) Neurogenic bladder 13) Chronic prostatitis 14) Complications during ureteroscopy such as ureteral perforation 15) Lower ureteral calculi
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in the change in the total points of IPSS and OABSS before and after ureteral stent placement between two groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Difference in change amount of each item of IPSS 2. Difference in change amount of each item of OABSS 3. Can it be a useful indicator when choosing a ureteral stent whose height is appropriate? 4. Difference in pain due to ureteral stent during ureteral stent placement | — |
Countries
Japan
Contacts
Public ContactMakoto Taguchi
Osaka Saiseikai Izuo Hospital Department of Urology
Outcome results
None listed